Market Movers

Humana Inc.’s Stock Price Slips to $362.85, Witnessing a Decline of 3.19%

Humana Inc. (HUM)

362.85 USD -11.97 (-3.19%) Volume: 0.75M

Humana Inc.’s stock price currently stands at 362.85 USD, experiencing a dip of -3.19% this trading session, with a trading volume of 0.75M. The healthcare giant’s stock has faced a significant drop of -20.74% YTD, indicating a challenging market scenario.


Latest developments on Humana Inc.

Action Lawsuits Have Been Filed Against Humana Inc. (NYSE: HUM)

Despite facing losses on the day, Humana Inc. stock has managed to outperform its competitors. Recent events include the opportunity for investors to lead a securities fraud lawsuit against the company with the Schall Law Firm. Additionally, a victory in a 401(k) excess fee case has boosted the company’s reputation. However, the stock still underperforms the market, as highlighted by various law firms filing class action lawsuits against Humana Inc. Investors are advised to stay informed and seek counsel to navigate these developments affecting the stock price movement.


Humana Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have provided insightful coverage of Humana Inc, a leading health insurance provider. In their report titled “Humana Inc.: Enhanced Strategic Management of Benefit Costs and Member Acquisition Tactics! – Major Drivers,” they highlighted the company’s mixed first-quarter results for 2024 and adjusted expectations for the upcoming year. Humana reaffirmed its full-year adjusted EPS guidance and increased its membership growth outlook, showcasing operational resilience and strategic expansions.

In another report by Baptista Research on Smartkarma, titled “Humana Inc.: Impacts on Pharmacy Benefit Managers (PBMs) Resulting From IRA Changes & Other Major Drivers,” the analysts discussed the company’s financial performance and future outlook. CEO Bruce Broussard and CFO Susan Diamond shared insights during a Q&A session, emphasizing Humana’s solid start in 2024 and reaffirming its full-year adjusted earnings per share guidance. This coverage provides valuable information for investors and stakeholders interested in Humana Inc‘s performance and growth strategies.


A look at Humana Inc. Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. has a balanced outlook according to Smartkarma Smart Scores, with a score of 3 across the board for Value, Dividend, Growth, and Resilience. This indicates a moderate overall outlook for the company in terms of these factors. However, Humana Inc. shows stronger momentum with a score of 4, suggesting positive market sentiment and potential for growth in the future.

As a managed health care company, Humana Inc. provides coordinated health care services to a wide range of customers in the United States and Puerto Rico. With offerings such as health maintenance organizations and preferred provider organizations, the company serves employer groups, government-sponsored plans, and individuals. Overall, Humana Inc. appears to be well-positioned in the market with a solid foundation for continued growth and success.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars